These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Usefulness of the disease activity scores for polymyalgia rheumatica for predicting glucocorticoid dose changes: a study of 243 scenarios. Binard A; De Bandt M; Berthelot JM; Saraux A; Arthritis Rheum; 2007 Apr; 57(3):481-6. PubMed ID: 17394219 [TBL] [Abstract][Full Text] [Related]
46. Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica. Nielsen BD; Dasgupta B Reumatismo; 2018 Mar; 70(1):1-9. PubMed ID: 29589397 [TBL] [Abstract][Full Text] [Related]
48. High angiopoietin-2 levels associate with arterial inflammation and long-term glucocorticoid requirement in polymyalgia rheumatica. van Sleen Y; Boots AMH; Abdulahad WH; Bijzet J; Sandovici M; van der Geest KSM; Brouwer E Rheumatology (Oxford); 2020 Jan; 59(1):176-184. PubMed ID: 31292652 [TBL] [Abstract][Full Text] [Related]
49. [Methods for assessment of disease activity of polymyalgia rheumatica]. Reisch M; Dejaco C Z Rheumatol; 2023 Jun; 82(5):368-379. PubMed ID: 37184675 [TBL] [Abstract][Full Text] [Related]
52. Polymyalgia rheumatica: inflammation suppression with low dose of methylprednisolone or modified-release prednisone. Benucci M; Olivito B; Manfredi M; Meacci F; Infantino M; Li Gobbi F; Sarzi-Puttini P; Marcassa C; Atzeni F Eur Rev Med Pharmacol Sci; 2015; 19(5):745-51. PubMed ID: 25807425 [TBL] [Abstract][Full Text] [Related]
53. The role of anticyclic citrullinated peptide antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica. Ceccato F; Roverano S; Barrionuevo A; Rillo O; Paira S Clin Rheumatol; 2006 Nov; 25(6):854-7. PubMed ID: 16514472 [TBL] [Abstract][Full Text] [Related]
54. Diagnosis and management of polymyalgia rheumatica. Jones O; Birrell F Practitioner; 2016 Dec; 260(1799):13-6. PubMed ID: 29020715 [TBL] [Abstract][Full Text] [Related]
55. Polymyalgia rheumatica--diagnosis and classification. Nesher G J Autoimmun; 2014; 48-49():76-8. PubMed ID: 24461540 [TBL] [Abstract][Full Text] [Related]
56. Calcium pyrophosphate deposition disease mimicking polymyalgia rheumatica: a prospective followup study of predictive factors for this condition in patients presenting with polymyalgia symptoms. Pego-Reigosa JM; Rodriguez-Rodriguez M; Hurtado-Hernandez Z; Gromaz-Martin J; Taboas-Rodriguez D; Millan-Cachinero C; Hernandez-Rodriguez I; Gonzalez-Gay MA Arthritis Rheum; 2005 Dec; 53(6):931-8. PubMed ID: 16342107 [TBL] [Abstract][Full Text] [Related]
57. Current diagnosis and treatment of polymyalgia rheumatica. De Bandt M Joint Bone Spine; 2014 May; 81(3):203-8. PubMed ID: 24462129 [TBL] [Abstract][Full Text] [Related]
58. Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate. A more benign syndrome. González-Gay MA; Rodríguez-Valverde V; Blanco R; Fernández-Sueiro JL; Armona J; Figueroa M; Martínez-Taboada VM Arch Intern Med; 1997 Feb; 157(3):317-20. PubMed ID: 9040299 [TBL] [Abstract][Full Text] [Related]
59. Performance of the polymyalgia rheumatica activity score for diagnosing disease flares. Binard A; de Bandt M; Berthelot JM; Saraux A; Arthritis Rheum; 2008 Feb; 59(2):263-9. PubMed ID: 18240260 [TBL] [Abstract][Full Text] [Related]